TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PSH0 Stock 12 Month Forecast
There Are No Analyst Ratings for DE:PSH0 In The Last 3 Months.
Highest Price Target―
Average Price Target―
Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
PSH0 Financial Forecast
PSH0 Earnings Forecast
Next quarter’s earnings estimate for PSH0 is >-€0.01 with a range of >-€0.01 to >-€0.01. The previous quarter’s EPS was >-€0.01. PSH0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year PSH0 has Performed in-line its overall industry.
Next quarter’s earnings estimate for PSH0 is >-€0.01 with a range of >-€0.01 to >-€0.01. The previous quarter’s EPS was >-€0.01. PSH0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year PSH0 has Performed in-line its overall industry.
No data currently available
PSH0 Sales Forecast
Next quarter’s sales forecast for PSH0 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. PSH0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year PSH0 has Performed in-line its overall industry.
Next quarter’s sales forecast for PSH0 is €0.00 with a range of €0.00 to €0.00. The previous quarter’s sales results were €0.00. PSH0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year PSH0 has Performed in-line its overall industry.
Research Capital analyst Andre Uddin keeps Speculative Buy rating on Sernova BiotherapeuticsUddin said Sernova reported its Q2 results, though financials remain secondary as the company is still in the clinical stage.
Research Capital analyst Andre Uddin keeps Speculative Buy rating on Sernova BiotherapeuticsUddin said Sernova reported its Q2 results, though financials remain secondary as the company is still in the clinical stage.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 3 Months would result in 37.50% of your transactions generating a profit, with an average return of -7.52% per trade.
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -29.40% per trade.
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -33.05% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PSH0 Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Dec 25
Jan 26
Feb 26
Strong Buy
4
4
3
1
0
Buy
0
0
0
0
0
Hold
0
0
1
41
56
Sell
3
0
0
16
19
Strong Sell
0
0
0
0
0
total
7
4
4
58
75
In the current month, PSH0 has received 0Buy Ratings, 56Hold Ratings, and 19Sell Ratings. PSH0 average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
PSH0 Stock Forecast FAQ
What is DE:PSH0’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:PSH0’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:PSH0, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Sernova Corp a Buy, Sell or Hold?
Currently, no data Available
What is Sernova Corp’s share price target?
Currently, no data Available
What do analysts say about Sernova Corp?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Sernova Corp?
To buy shares of DE:PSH0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.